A breakthrough clinical trial in Japan reveals that nicotinamide riboside (NR), a vitamin B3 derivative, significantly improves symptoms of the rare premature aging disease Werner syndrome.

Patients saw boosted cardiovascular health, reduced skin ulcers, and slower kidney decline—all without serious side effects. This is the first evidence that targeting NAD+ depletion could address WS’s underlying biology.

https://scitechdaily.com/vitamin-b3-pill-rewinds-premature-aging-in-groundbreaking-human-trial/